C. Becerra

发表

A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer

M. Sherman, A. Hezel, A. El-Khoueiry, 2015, Clinical Cancer Research.

The safety of IPI-926, a novel hedgehog pathway inhibitor, in combination with gemcitabine in patients (pts) with metastatic pancreatic cancer.

C. Fuchs, J. Hamm, B. Wolpin, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma

David A. Smith, D. V. Von Hoff, L. Marton, 2020, Cancer Chemotherapy and Pharmacology.

Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors

M. Galsky, D. V. Von Hoff, R. McWilliams, 2016, Oncology.

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kazuhiro Yoshida, A. Benson, Y. Bang, 2018, The Lancet.

A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers

B. Wolpin, D. V. Hoff, A. Ko, 2016, Investigational New Drugs.

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study

C. Obasaju, D. Richards, L. Wilfong, 2011, Investigational New Drugs.

Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study

M. Goetz, M. Beeram, H. Burris, 2022, Frontiers in Oncology.

An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: A multicenter cohort study.

Joon-Oh Park, S. Yamada, Y. Kodera, 2022, Gastroenterology.

A phase Ib trial of IPI-926, a hedgehog pathway inhibitor, plus gemcitabine in patients with metastatic pancreatic cancer.

C. Fuchs, J. Hamm, B. Wolpin, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

D. Berry, S. Cummings, E. Fung, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer

M. Sherman, A. Hezel, A. El-Khoueiry, 2015, Clinical Cancer Research.